Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Validity Diagnostics is a private diagnostics company that develops and manufactures specimen validity testing reagents, calibrators, controls, and related laboratory products used in urine drug screening. The company focuses on detecting adulteration, substitution, dilution, oxidative adulterants, and synthetic urine in clinical and workplace toxicology testing workflows. Its products are designed for use on standard high-speed immunoassay and chemistry analyzers, including automated laboratory platforms. Validity Diagnostics markets a 2nd generation 5-test SVT panel and positions its technology as a way to reduce false negatives and improve confidence in toxicology results. The business appears to operate as a commercial-stage supplier of laboratory diagnostics rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Validity Diagnostics.